Accumulating new evidence has identified that INSM1, a transcriptional regulator with a zinc-finger DNA-binding domain, may function as a cytoplasmic biomarker for neuroendocrine differentiation of tumor cells (Rosenbaum et al., 2015). Here, INSM1 is linked to neoplasm.